ERIS

Eris Lifesciences Limited

Pharmaceuticals · ₹19,836 Cr market cap

A pharmaceutical manufacturer and marketer, ERIS Lifesciences produces branded and generic drugs across multiple therapeutic areas including cardiovascular, gastroenterology, and anti-infective segments. The company operates manufacturing facilities and distributes medications through established distribution networks to serve both domestic and international markets. It focuses on developing and delivering cost-effective pharmaceutical formulations for diverse patient populations.

0
Tracked investors holding
0
Tracked moves
1,430
Share price

Track smart money in Eris Lifesciences Limited

Get alerted when a top investor buys or sells.

Get started
Eris Lifesciences Limited — investor holdings & smart-money activity · WhaleWatch